Fingerprint
Dive into the research topics of 'PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells
Otto Kauko, Caitlin M. O’Connor, Evgeny Kulesskiy, Jaya Sangodkar, Anna Aakula, Sudeh Izadmehr, Laxman Yetukuri, Bhagwan Yadav, Artur Padzik, Teemu Daniel Laajala, Pekka Haapaniemi, Majid Momeny, Taru Varila, Michael Ohlmeyer, Tero Aittokallio, Krister Wennerberg, Goutham Narla, Jukka Westermarck*
*Corresponding author for this work